Aaron M. Teitelbaum, Ph.D.

2012 Medicinal Chemistry University of Minnesota, Twin Cities, Minneapolis, MN 
Pharmacy, Organic Chemistry
"Aaron Teitelbaum"
Mean distance: (not calculated yet)


Sign in to add mentor
Rory P. Remmel grad student 2012 UMN
 (Pre-clinical Drug Development of 9-aminoacridines for Malignant Glioma and Meropenem Prodrugs for Drug-Resistant Tuberculosis.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Teitelbaum AM, Scian M, Nelson WL, et al. (2015) Efficient Syntheses of Vitamin K Chain-Shortened Acid Metabolites. Synthesis. 47: 944-948
Teitelbaum AM, Meissner A, Harding RA, et al. (2013) Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis. Bioorganic & Medicinal Chemistry. 21: 5605-17
Wilson DJ, Shi C, Teitelbaum AM, et al. (2013) Characterization of AusA: a dimodular nonribosomal peptide synthetase responsible for the production of aureusimine pyrazinones. Biochemistry. 52: 926-37
Teitelbaum AM, Gallardo JL, Bedi J, et al. (2012) 9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma. Cancer Chemotherapy and Pharmacology. 69: 1519-27
Vasan M, Neres J, Williams J, et al. (2010) Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening. Chemmedchem. 5: 2079-87
See more...